Log In
Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Forgot your password?
Log In
Don't have an account? Sign Up Here
Join Us
Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
I agree to TheMaven's
Terms
and
Policy
Sign Up
Already have an account? Login here
JIM CRAMER
INVESTING
PERSONAL FINANCE
RETIREMENT
TECHNOLOGY
MARKETS
HOW-TO
VIDEO
FINANCIAL ADVISOR CENTER
Search
Trade with Jim Cramer 14 Days Free
Join the Action Alerts PLUS Community today!
SUBSCRIBE NOW
LATEST NEWS
JIM CRAMER
Cue the Buying: Cramer's 'Mad Money' Recap (Monday 9/21/20)
By Scott Rutt
Sep 21, 2020 11:10 PM EDT
PRESS RELEASES
Arrowhead Pharmaceuticals To Webcast Fiscal 2021 First Quarter Results
By Business Wire
Jan 19, 2021 4:00 PM EST
PRESS RELEASES
Arrowhead Pharmaceuticals Reports Inducement Grants Under NASDAQ Marketplace Rule 5635(c)(4)
By Business Wire
Dec 7, 2020 4:10 PM EST
PRESS RELEASES
Arrowhead Pharmaceuticals To Participate In Upcoming Conferences
By Business Wire
Nov 30, 2020 4:00 PM EST
PRESS RELEASES
Arrowhead Pharmaceuticals Announces Closing Of Agreement With Takeda
By Business Wire
Nov 25, 2020 7:30 AM EST
PRESS RELEASES
Arrowhead Presents New Clinical Data On Cardiometabolic Pipeline At AHA 2020
By Business Wire
Nov 13, 2020 10:00 AM EST
PRESS RELEASES
Arrowhead Pharmaceuticals To Participate In Upcoming Conferences
By Business Wire
Nov 9, 2020 7:30 AM EST
PRESS RELEASES
Arrowhead Pharmaceuticals To Host Key Opinion Leader Webinars On Cardiometabolic Candidates ARO-APOC3 And ARO-ANG3
By Business Wire
Nov 4, 2020 7:30 AM EST
PRESS RELEASES
Arrowhead Pharmaceuticals To Webcast Fiscal 2020 Year End Results
By Business Wire
Nov 2, 2020 4:00 PM EST
PRESS RELEASES
Takeda And Arrowhead Collaborate To Co-Develop And Co-Commercialize ARO-AAT For Alpha-1 Antitrypsin-Associated Liver Disease
By Business Wire
Oct 8, 2020 7:30 AM EDT
PRESS RELEASES
Arrowhead Pharmaceuticals To Participate In Upcoming Investor Conference
By Business Wire
Sep 30, 2020 4:01 PM EDT
PRESS RELEASES
Arrowhead Pharmaceuticals Reports Inducement Grants Under NASDAQ Marketplace Rule 5635(c)(4)
By Business Wire
Sep 24, 2020 4:30 PM EDT
JIM CRAMER
Cue the Buying: Cramer's 'Mad Money' Recap (Monday 9/21/20)
By Scott Rutt
Sep 21, 2020 11:10 PM EDT
STOCKS
AMC Networks, Eastman Kodak: 5 Top Stock Gainers for Wednesday
By Rob Lenihan
Sep 16, 2020 4:20 PM EDT
PRESS RELEASES
Arrowhead ARO-AAT Phase 2 Interim Results In Patients With Alpha-1 Liver Disease Demonstrate Improvements In Key Parameters After Six Months Of Treatment
By Business Wire
Sep 16, 2020 7:30 AM EDT
PRESS RELEASES
Arrowhead Pharmaceuticals Appoints Oye Olukotun To Board Of Directors
By Business Wire
Sep 8, 2020 7:30 AM EDT
PRESS RELEASES
Arrowhead Pharmaceuticals To Participate In Upcoming September 2020 Conferences
By Business Wire
Sep 8, 2020 7:30 AM EDT
PRESS RELEASES
Arrowhead Presents Positive New Phase 1/2 Clinical Data On Cardiometabolic Candidates ARO-APOC3 And ARO-ANG3 At European Society Of Cardiology Congress 2020
By Business Wire
Aug 31, 2020 4:50 AM EDT
PRESS RELEASES
Arrowhead And Collaborator Janssen Present Phase 2 Clinical Data On Investigational Hepatitis B Therapeutic JNJ-3989 At The Digital Liver Congress
By Business Wire
Aug 28, 2020 7:30 AM EDT
PRESS RELEASES
Arrowhead Pharmaceuticals Initiates Phase 1b Study Of ARO-HIF2 For Treatment Of Clear Cell Renal Cell Carcinoma
By Business Wire
Aug 18, 2020 7:30 AM EDT
PRESS RELEASES
Arrowhead Pharmaceuticals Initiates Dosing Phase 1/2 Study Of ARO-ENaC For Treatment Of Cystic Fibrosis
By Business Wire
Aug 11, 2020 7:30 AM EDT
PRESS RELEASES
Arrowhead Pharmaceuticals Earns $20 Million Milestone Payment From Amgen For Start Of Phase 2 Trial Of AMG 890
By Business Wire
Jul 29, 2020 7:30 AM EDT
PRESS RELEASES
Arrowhead Pharmaceuticals Hosts Key Opinion Leader Webinar On ARO-ENaC For Treatment Of Cystic Fibrosis
By Business Wire
Jul 28, 2020 11:59 AM EDT
PRESS RELEASES
Arrowhead Pharmaceuticals Reports Inducement Grants Under NASDAQ Marketplace Rule 5635(c)(4)
By Business Wire
Jul 24, 2020 4:10 PM EDT
PRESS RELEASES
Arrowhead Pharmaceuticals To Host Key Opinion Leader Webinar On ARO-ENaC For Treatment Of Cystic Fibrosis
By Business Wire
Jul 9, 2020 7:30 AM EDT
